IRMA

BOOG 2009-01

General Information

BOOG number

BOOG 2009-01

Nickname

IRMA

Status

Date: 05/02/2019

Inclusion closed

05/02/2019

Participating parties / group

PRI ER (It)

Full title

IRMA study protocol. Breast cancer with low risk of local recurrence: partial and accelerated radiation with three-dimensional conformal radiotherapy (3DCRT) vs. standard radiotherapy after conserving surgery

Indication

Subindication

Not applicable

Target sample size

3302

Actual accrual

3302 (NL 830)
Date: 05/02/2019

Estimated study completion date

01/07/2018

Contact

Sponsor

Modena University Hospital

Principal Investigator(s)

Ph. Poortmans-L.J. Boersma

Study manager

A.E. van Leeuwen-Stok

Central datamanagement and randomization

Clinical Trials Office, University of Modena Tel. +39 059 422 3865 roberto.vicini@unimore.it

Monitoring

Quality assurance RT via dummy runs

Local datamanagement

IKNL

Funding

Funding KWF-CKS

Design

Randomization: Experimental arm: 38.5 Gy total in 10 fractions (3.85 Gy per fraction), twice a day with an interval of at least 6 hours between the two fractions, for five consecutive working days. Control arm: 45 Gy/18 fractions, or 50 Gy/25 fractions, or 50,4 Gy/28 fractions, or iso-effective fraction schemes, once a day for 5 days a week. A 10 – 16 Gy boost is allowed in centers where it is part of the standard treatment.

Objectives

To evaluate whether partial hypofractionated and accelerated irradiation of the sole surgical cavity, in patients suffering from breast cancer with low risk of local recurrence and undergoing conservative surgery, is not inferior to postoperative irradiation with conventional fractionation of the entire breast as regards local control, measured in terms of incidence of ipsilateral recurrences as first event.

Endpoints

Primary endpoint:

  • Local ipsilateral recurrence as first event free survival

Secondary endpoints:

  • Overall survival
  • Locoregional recurrence-free survival
  • Distant recurrence-free survival
  • Acute and late toxicity (RTOG)
  • Cosmetic result

Eligibility Criteria

Female, pT 1-2 (< 3 cm in diameter) pN0-N1 M0 Unifocal Histologically negative resection margins (≥ 2 mm) at first intervention or after subsequent widening Undergoing conservative breast surgery for invasive breast cancer

Regulatory Information

CCMO approval

Yes
Nr: NL 27657.028.09

EC approval

Yes
Date: 18/02/2010
Nr:M234

EC

Sint Elisabeth Ziekenhuis
Amendments:
Yes
Date Last Amendment: 06/12/2009

EudraCT number

Not applicable

Downloads

Inloggen